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Immune complexes composed of DNA and antibodies to DNA contribute to tissue 
injury in systemic lupus erythematosus (SLE)  (1, 2). High titers of antibodies to both 
single-stranded  DNA  (ssDNA)  and  double-stranded  DNA  (dsDNA)  are  associated 
with the disease  (2,  3), and antibodies to DNA have been eluted from the kidneys of 
SLE  patients  (4,  5).  Direct  demonstration  of circulating  DNA-anti-DNA  immune 
complexes has been reported  (6, 7), but not confirmed (8). 
Whereas the fate of circulating immun  e complexes such as HSA-anti-HSA has been 
well characterized  (9),  the behavior of immune complexes containing DNA has not 
been  studied.  DNA  is  cleared  from  the  circulation  extremely  rapidly,  faster  than 
large-latticed  complexes  (10).  Furthermore,  in  vitro  DNA binds  to glomerular  and 
skin basement  membranes  (11). These unique features of DNA might also influence 
the fate of immune complexes containing DNA as the antigen. In this study, immune 
complexes were prepared in vitro with ssDNA and antibodies to DNA from a patient 
with  SLE.  The  clearance  and  organ  localization  of these  immune  complexes  was 
studied  in normal mice and compared with the clearance of heat aggregated immu- 
noglobulin (IgG), serving as a model for immune complexes. Our results demonstrate 
that the clearance of ssDNA-anti-DNA immune complexes parallels the clearance of 
DNA alone and is much more rapid than the clearance of aggregated IgG. 
Materials  and Methods 
Antibodies to DNA.  Serum from a  patient  with active SLE, kindly provided by Dr. J.  V. 
Jones of the University of Chicago, was precipitated with 50% saturated ammonium sulphate 
and  resuspended  in borate buffer (0.2 M  borate, 0.15  M  NaCI; pH 8.0).  This material  was 
radiolabeled with 125I by the iodine monochloride method (12), and free 125I was removed by 
dialysis  (final  sp  act  30,000  epm//~g).  This  preparation,  containing  IgM and  IgG, was  gel 
filtered over Sepharose 4B (Pharmacia Fine Chemicals,  Div. of Pharmaeia Inc., Piscataway, 
N  J)  and the included IgG peak was pooled (see Figure  1 A). Reehromatography of this peak 
showed no excluded protein. 
ssDNA.  Calf thymus  DNA  (Worthington  Biochemical  Corp.,  Freehold,  N  J)  was  heat 
denatured and labeled with laxI according to the method of Commerford (13). After dialysis to 
remove free xa'I, the DNA was passed over Sepharose 4B, and the excluded material was pooled 
(Fig.  1 B). Analysis of this DNA on 2% agarose gel electrophoresis revealed a mean mol wt of 
640,000  with a range of 400,000-800,000. 
Preparation of Immune Complexes.  I0 mg of 125I IgG was mixed with 20/~g of lalI ssDNA and 
incubated at 37°C for 30 rain.  This mixture  (2 ml)  was gel filtered on a 50-ml Sepharose 4B 
column,  and  the  125I and  131I counts  per 0.5  ml  fraction  were  determined  (Fig.  1C).  The 
excluded material was pooled, analyzed, and used as immune complex in animal studies. 
* Supported by grant AM 24015 from the National Institutes of Arthritis, Diabetes and Digestive and 
Kidney Diseases. 
1210  J. ExP. MED. © The Rockefeller  University Press • 0022-1007/82/04/1210/06 $1.00 
Volume 155  April  1982  1210-1215 EMLEN  AND MANNIK  BRIEF  DEFINITIVE REPORT  12tl 
~o 
,o 
.r  J  i  "~,', ' 
10  20  30  40  10  20  30 
10 
i 
,o  ~  3'o 
10 
Elution volume (rnl) 
FIG.  l.  Preparation of ssDNA-anti-DNA immune complexes. Serum from a patient with SLE with 
high DNA binding was precipitated with 50% ammonium sulfate and gel filtered on a Sepharose 
4B column (A). The Sepharose 4B excluded pool of heat-denatured calf thymus DNA was obtained 
(B). The IgG pool (l~] cpm X 10  -5 ['  ]) from (A) and the ssDNA pool (lslI cpm ×  10 -4 [- - -]) 
from (B) were combined and incubated at 37°C for 30 min. This mixture was  then passed  over 
Sepharose  4B (C) and the excluded material, as indicated by the bar, was characterized and used 
in animal experiments. 
Analysis  oj  c Immune  Complexes.  IgG/DNA  molar  ratios  in  the  immune  complexes  were 
calculated using the specific activity of each preparation and a  tool wt of 145,000 for IgG and 
640,000  for ssDNA. In these calculations, all the IgG in the excluded peak was assumed to be 
in the form of immune complexes. To rule out the possibility that  IgG was simply aggregated 
or coeluting  with  DNA,  rather  than  actually  binding  to  DNA,  a  modified  Farr  assay  was 
performed on the immune complexes.  50 pl of immune complexes were mixed with  50/d  of 
Cohn Fraction II (Miles Laboratories, Elkhardt, IN) as carrier protein and  100/~1 of saturated 
ammonium sulfate. After 1 h at 4°C, the samples were spun and  100 #1 of the supernatant  was 
removed. The precipitate (P) and supernatant  (S) were counted, and the percent of asaI DNA 
in the complexes bound to IgG was calculated by the formula: P  -  S/P +  S. 
Preparation of IgG.  Monomeric IgG was prepared  from Cohn  Fraction  II by gel filtration 
over  Sephadex  G200  (Pharmacia  Fine  Chemicals)  and  labeled  with  125I (12).  Aggregated 
human IgG (AHGG) was kindly prepared by Dr. Richard Jimenez from Cohn Fraction II by 
ion exchange chromatography  on DEAE cellulose (Pharmacia  Fine Chemicals),  followed by 
heating at 63°C for  10 min in 0.1  M  Tris-HCL, 0.15  M  NaC1, pH 7.55  (14).  Aggregates were 
separated  by size on Sepharose 4B, and the intermediate molecular weight pool was concen- 
trated  and  labeled.  After passage over Sephadex  G200  to  remove monomer,  the aggregates 
were dialyzed against borate and used in animal experiments. The size of these aggregates was 
22-25 S by linear 10-40% sucrose density gradients. 
Animal  Studies.  All  experiments  were  performed  on  3-4-mo-old  female  C57B1/6J  mice 
weighing 20-25 g (The Jackson Laboratory, Bar Harbor, ME) without detectable antibodies to 
DNA.  Animals were  placed  on  iodized water  24  h  before experiments.  Immune  complexes 
containing 5/~g antibody, AHGG, or monomeric IgG in 0.5 ml borate were injected into the 
lateral tail vein, and blood samples were obtained from the retro-orbital venous plexus at 0.5, 
1,  2, 3,  5,  10,  20, and  30 min and  1,  2, 4, and 6  h.  Blood samples were mixed with an equal 
volume of cold 10% trichloroacetic acid (TCA) and spun in a microfuge. The supernatant  was 
removed,  and  the  125I (IgG)  and  lzlI  (DNA)  counts  in  the TCA-preeipitable  fraction  were 
determined.  Organ uptake experiments were performed as above except that  after the 3 min 
blood sample,  animals  were sacrificed by cervical dislocation,  and  the liver, spleen, kidneys, 
and lungs were removed and counted for t25I and 131I. 
TCA-preeipitable lzsI (IgG) and lalI (DNA) counts remaining at each time point were plotted 
on semilogarithmic paper, and the slope and y intercept of the linear portion of the disappear- 
ance curves were calculated by linear regression analysis. Half-lives for each individual animal 
were calculated  according to the formula  tl/z =  -0.693/2.303K,  where  K  is the slope of the 
disappearance curve. Clearance rates for groups of animals were calculated by taking the mean 
of the half-lives of individual animals in each group. 
Organ uptake in/Lg IgG (or DNA) was calculated by dividing the counts per organ by the 
specific activity of the IgG  (DNA). All statistical analyses were performed using a  two-tailed 
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Results 
Characteristics of Immune Complexes.  Less than 0.5% of the IgG added to the ssDNA 
bound to the DNA and eluted in the excluded fraction of the Sepharose column (Fig. 
1 C). Because of the low yield and limited amounts of serum, we produced only small 
amounts of complexes for animal studies, and consequently the dose of administered 
complexes was small. 
Analysis  of  the  DNA-anti-DNA  immune  complexes  by  rechromatography  on 
Sepharose 4B at room temperature 24 h  after preparation showed <5% monomeric 
IgG, and  50%  saturated  ammonium  sulfate  precipitated  80%  of the  DNA  in  the 
complexes.  Thus,  the  immune  complexes  contained  only  small  amounts  of  free 
antibody (5%) and free antigen (20%). All complexes used in animal studies were used 
within  12 h of preparation. 
The ratio of IgG to DNA in  these immune complexes was 2.5/~g IgG//~g DNA, 
yielding a  molar ratio of 7-15  (mean  10)  IgG molecules per DNA.  The used  DNA 
had an average size of 1,900  bases, corresponding to -1  IgG molecule/190 bases. 
Clearance of Immune Complexes.  ssDNA-anti-DNA immune complexes containing 5 
/~g antibody were cleared extremely rapidly from the circulation  (Fig.  2).  The anti- 
DNA and DNA in the immune complexes were cleared at similar rates; the half-life 
of anti-DNA was 2.1  +  0.3 min, and the t½ of DNA was 1.6 +  0.6 min. Both of these 
rates closely approximated  the  previously reported  (10)  clearance  rate of an  equal 
dose (2/~g) of ssDNA alone, which was  1.4 --. 0.2 minutes. 
Because we  administered  DNA-anti-DNA  immune complexes containing  only  5 
/~g of IgG, it was possible that the rapid clearance was in part due to the small size of 
the  dose.  To directly investigate this  possibility, we prepared aggregates of human 
IgG (AHGG) of a  specific molecular weight range (22-25  S)  so that each aggregate 
contained  a  comparable  number  of IgG molecules  (9-11)  as  the  DNA-anti-DNA 
immune  complexes.  This  surrogate  for immune  complexes was  specifically chosen 
because of the physical size, homogeneity, and comparable number of IgG molecules 
per aggregate, in contrast to other immune complexes studied in our laboratories (9). 
The clearance kinetics of an identical dose (5 ~g) of AHGG are shown in Fig. 2. The 
initial clearance rate of AHGG (0/2 =  6.5 +  1.8 min) was significantly slower than the 
clearance of the IgG in the DNA-anti-DNA immune complexes (t½  =  2.1  +  0.3,  P 
<  0.01). 
The late clearance component of AHGG, DNA-anti-DNA immune complexes, and 
monomeric IgG is shown in the Fig. 2 insert. From 2 to 6 h  the disappearance curves 
of all three substances were parallel (t½ IgG --- 6.1  h, AHGG -- 8.8 h, anti-DNA =  7.2 
h). However, between  10 rain and 2 h  the disappearance of anti-DNA was strikingly 
different  from  monomeric  IgG and  AHGG.  The  amount  of monomeric  IgG and 
AHGG remaining in the circulation decreased gradually and steadily over time, but 
the clearance of anti-DNA virtually stopped from 10 rain to 2 h. The amount of anti- 
DNA remaining in the circulation at  1 and 2 h was higher (although not statistically 
significant)  than the amount remaining at  10 min. Extrapolating this curve to the y 
axis (time 0)  indicated that this component of the clearance curve accounted for 20% 
of the  starting preparation,  and  thus  exceeded the  amount  of free antibody in  the 
injected  preparation.  The x31I radioactivity on  DNA could  not  be followed beyond 
the initial rapid clearance because of the low counting rates. 
Organ Uptake.  The liver was the main organ of uptake for ssDNA, anti-DNA, and 
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Fro.  2.  Clearance ofTCA-precipitable radioac- 
tivity in DNA-anti-DNA immune complexes from 
the circulation.  Each  point  represents the mean 
from at least five mice. The initial clearance (0-5 
rain)  of attti-DNA  (A)  in  the  DNA-anti-DNA 
immune complexes is significantly faster than the 
clearance of IgG in AHGG (0)  (P <  0.01). DNA 
(11) in the DNA-anti-DNA immune complexes is 
cleared  at  the same rate  as  DNA alone.  Insert: 
clearance  of monomerie  IgG  (O),  AHGG,  and 
anti-DNA is parallel from 2-6 h. From  10 rain to 
2  h,  however,  the  anti-DNA  levels  did  not  de- 
crease, hut increased slightly, indicating that some 
anti-DNA returned to the circulation. 
AHGG  (P <  0.05, data not shown).  No significant differences were found between 
AHGG uptake and DNA-anti-DNA immune complex uptake in any other organs. 
Discussion 
To study the biological properties of immune complexes containing DNA, factors 
such as DNA size, antigen-antibody molar ratios, and DNA configuration (ss vs. ds) 
should be defined (15).  Only by using well defined complexes can the effect of each 
of these parameters on the in  vivo behavior and  pathogenicity of DNA-anti-DNA 
immune complexes be ascertained. In this study, we examined the clearance kinetics 
in normal mice of a defined subset of immune complexes containing large molecular 
weight ssDNA (mol wt 6 ×  10  ~) with 1 IgG molecular bound per 190-200 bases. Both 
the antigen and antibody in these immune complexes were cleared extremely rapidly 
by the liver, at a rate approaching the clearance of antigen (DNA) alone. 
The administered DNA-anti-DNA complexes contained a comparable number of 
IgG molecules as the aggregated IgG probe. Therefore, the fast clearance of DNA- 
anti-DNA complexes that approached the clearance of DNA alone indicated that the 
DNA  in  the  complexes altered  the clearance of these  immune  complexes.  Recent 
studies have demonstrated that antigens can alter the clearance of immune complexes 
independent  of their lattice  (16,  17).  The  presented  data  indicate  that  the  rapid 
clearance  of the  ssDNA  also  leads  to  enhanced  clearance  of immune  complexes 
containing ssDNA. 
Analysis  of the  disappearance  of DNA-anti-DNA  complexes beyond  the  initial 
clearance revealed highly interesting events. The TCA-precipitable counts of 125I-anti- 
DNA actually increased beyond 10 min samples, and after 2 h declined parallel with 
monomeric IgG. Previous studies on the removal of immune complexes from circu- 
lation did not show increased TCA precipitable counts as seen with DNA-anti-DNA 
(18).  The y  intercept of this slow removal phase of anti-DNA was  20%,  indicating 
that  >20%  of the  injected anti-DNA was  removed with  a  tl/2 of 7.2  h,  because no 1214  EMLEN AND MANNIK  BRIEF  DEFINITIVE REPORT 
allowance was made for equilibration  between  the intravascular and extravascular 
spaces. It was unlikely that this fraction represented noncomplexed anti-DNA, because 
even stored aliquots of the injected complexes contained <5% of unbound anti-DNA 
on gel filtration. Therefore, either free 125I-anti-DNA or 125I-anti-DNA bound to small 
DNA fragments returned  to the circulation.  This would occur if the large ssDNA in 
some complexes reacted with surface nucleases in the liver, as previously postulated 
(10),  and  upon  degradation  free  anti-DNA  or  anti-DNA  bound  to  small  DNA 
fragment were released into circulation. 
A  number of investigators have shown in vitro that free antibody is released from 
DNA-anti-DNA immune complexes by digestion with  deoxyribonucleases  (DNAse) 
(19, 20). Recently, Sano and Morimoto (21) showed that immune complexes from the 
sera of SLE patients contained small molecular weight DNA, and other investigators 
(22)  found that, whereas DNAse digestion decreased the size of complexes, some IgG 
remained bound to small DNA fragments. We postulate that the second component 
of the  observed  anti-DNA  clearance  curve  represents  the  release  and  subsequent 
clearance of either free anti-DNA or small immune complexes containing anti-DNA 
bound  to small  DNA fragments. This latter possibility could not  be excluded  with 
certainty because the radioactivity of the laI-DNA became too low to be followed. 
This study represents  the  first  characterization  of the  in  vivo fate of DNA-anti- 
DNA immune complexes. We have shown that the clearance of well defined ssDNA- 
anti-DNA immune complexes is influenced by the antigen  in the complexes and is 
extremely rapid. Whether or not this clearance mechanism applies to all DNA-anti- 
DNA  complexes  is  not  known.  Examination  of the  influence  of antigen  size  and 
antigen/antibody ratios on the clearance, tissue deposition and in vivo degradation of 
DNA-anti-DNA immune complexes awaits further study. 
Summary 
DNA-anti-DNA immune complexes, produced from single-stranded DNA and IgG 
from a  patient with systemic lupus erythematosus were cleared from the circulation 
of normal mice extremely rapidly, at a  rate similar to the clearance of DNA alone. 
The  initial  clearance  of  these  complexes  was  more  rapid  than  the  clearance  of 
aggregated IgG, a  surrogate  immune complex containing  a  comparable number of 
IgG molecules,  suggesting  that  the  antigen  (DNA)  in  the  complexes  significantly 
altered the clearance kinetics of the complexes. Analysis of the late clearance compo- 
nent of these complexes showed that anti-DNA is released back into the circulation 
after initial removal, and is then cleared at a rate similar to monomeric IgG. Whether 
this anti-DNA represents free antibody, or antibody bound to small nuclease digested 
DNA fragments, awaits further study. 
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